Abbott Laboratories (Pakistan) Limited reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was PKR 16,028.93 million compared to PKR 13,805.92 million a year ago. Revenue was PKR 16,028.93 million compared to PKR 13,805.92 million a year ago.

Net income was PKR 1,518.76 million compared to net loss of PKR 219.52 million a year ago. Basic earnings per share from continuing operations was PKR 15.51 compared to basic loss per share from continuing operations of PKR 2.24 a year ago.